As reported in the Wall Street Journal and the New York Times, Camber Pharma’s Amlodipine, the generic for blood-pressure drug Norvasc has made an immediate and substantial impact on the generics marketplace quickly building a 9 percent share of the overall sales. To view the complete article click the link below.
http://blogs.wsj.com/health/2010/04/05/generic-business-faces-tougher-slog/
